We always knew that Spike-protein was a hotspot for mutation and we now observe that there is a very high number of variants and therefore mutations in these mRNA viruses. So, this result is both predictable and unsurprising. Furthermore, if you consider that, if one wanted to create variants in a virus then the most viable route would be to change tangents in the Spike.
Furthermore, there are a high number of potential binding sites for S-protein within the body; The S-protein receptors are ACE2, CD 1 4 7, CD 26, TLR and GP2b3a and Neuropilin-1.
Another concern is the circulation of Spike-protein within the brain.
A very recent paper shows that the Spike-proteins would induce pathological changes in the delivery and the metabolic function within the brain.
Dr. Alexandra Henrion Caude and her team wrote a letter to the European Medicinal Agency (the EMA) about this concern and the EMA did reply to say that the injections would be leading to cancer or toxicity. And so, Dr. Alexandra Henrion Caude and her team wrote to ask what they were doing to circumvent or to trace any of these aspects.
The first part of the answer was to say that they didn’t do the studies because it would take time and money and human resource constraints to do such studies.
This is very puzzling when you consider that we are injecting billions of doses. The other part of the answer was also a bit puzzling, focusing on one of the lipid nanoparticles (ALC 0 1 5 9). And they were saying that one shouldn’t really worry as to the toxicity of this specific LNP, because they were using low doses of it and we were to only inject it twice!
Maybe they didn’t know that the idea was to repeatedly use this injection and to have boosters?
Dr. Alexandra Henrion Caude’s Main Concerns:
> Activation of sleeping andogenous viral genome sequence, typically the H E R V – W envelope.
> SARS-CoV-2 as well as Spike-protein stimulation leads to an increased expression of this sleepy messenger in our cells. Eliciting a number of concerns that the production of an envelope of H E R V – W can lead to.
> Spike-protein impairs the DNA and inhibits VDJ recombination.
> The mitochondrial dynamics are altered by Spikeprotein alone.
> Spike-protein in the endothelial cells is also problematic.
> Spike-protein can enter brain endothelial cells.
A Final Message From Dr. Alexandra Henrion Caude – What To Expect:
Antibody-Dependent Enhancement and enhanced respiratory diseases.
Downstream consequences of the mRNA injection (mRNA sickness) typically resulting from the LNPs (Lipid Nano Particles).
Metal contaminants in Pfizer, and Moderna in that studies coming out of Japan show metal contaminants which will lead to some sickness.
At the very least everyone should be encouraged to diminish the quantity of Spike-protein that is bound to the receptors and therefore to use any sort of strategy that would help to alleviate the possibility of it to bind.